REGN13335

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for REGN13335, covering 2025-03-19 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH) [Phase 2]